Skip to main content
Equibles
LGND logo

LGND · Ligand Pharmaceuticals Inc · Proposed Sales

Track LGND — free

Use LGND with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LGND.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$322.75 +5.42 (+1.71%) At close · Oct 30 Q3 2026 earnings call transcript
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$6.43B
Shares
20.00M
Volume · Oct 30 344.37K Avg daily vol (3M) 241.18K

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-10-30 JASON M ARYEH 1,209
2026-10-30 Aryeh Jason 202
2026-09-10 MARTINE ZIMMERMANN 1,200
2026-09-03 ANDREW REARDON 15,000
2026-08-12 OCTAVIO ESPINOZA 31,641
2026-08-12 Jason Haas 7,138
2026-07-01 ANDREW REARDON 10,000
2026-06-16 STEPHEN L. SABBA 2,145
2026-06-12 JASON HAAS 6,461
2026-06-11 Aryeh Jason 4,500
2026-06-10 Aryeh Jason 5,000
2026-06-10 Aryeh Jason 500
2026-06-10 JOHN L LAMATTINA 4,519
2026-05-13 JOHN KOZARICH 1,575
2026-05-12 JOHN KOZARICH 459
2026-05-01 KOZARICH JOHN W 467
2026-04-01 KOZARICH JOHN W 467
2026-03-23 STEPHEN L. SABBA 1,000
2026-03-11 OCTAVIO ESPINOZA 3,057
2026-03-06 JOHN L LAMATTINA 2,161
2026-03-04 ANDREW REARDON 20,000
2026-03-04 OCTAVIO ESPINOZA 13,423
2026-03-03 STEPHEN L. SABBA 2,034
2026-02-02 KOZARICH JOHN W 467
2026-01-02 KOZARICH JOHN W 467
2025-12-12 OCTAVIO ESPINOZA 1,804
2025-12-01 KOZARICH JOHN W 467
2025-11-07 NANCY GRAY 6,571
2025-11-07 JOHN L LAMATTINA 4,179
2025-11-03 KOZARICH JOHN W 467
2025-10-01 KOZARICH JOHN W 467
2025-09-23 JASON M ARYEH 10,000
2025-09-17 Aryeh Jason 10,000
2025-09-02 KOZARICH JOHN W 467
2025-08-01 KOZARICH JOHN W 467
2025-07-10 KOZARICH JOHN W 934
2025-06-23 ANDREW THOMAS REARDON 500
2025-06-10 ANDREW THOMAS REARDON 500
2025-05-15 ANDREW THOMAS REARDON 1,000
2025-03-18 Sabba Stephen L 2,406
2025-03-04 Espinoza Octavio 5,000
2024-12-23 Espinoza Octavio 2,104
2024-11-27 LAMATTINA JOHN L 2,406
2024-11-12 Korenberg Matthew E 32,183
2024-09-23 Korenberg Matthew E 14,437
2024-09-23 Reardon Andrew 2,000
2024-09-20 Korenberg Matthew E 6,275
2024-09-20 Espinoza Octavio 1,275
2024-08-28 Reardon Andrew 1,500
2024-08-22 Korenberg Matthew E 18,858
Showing 1–50 of 64 filings
Key facts CIK 886163 CUSIP 53220K504 13F (30d) 134 filings 125 filers Visit website Investor relations